USPTO serial 79451155
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical products for use in industry and science and photography, in particular monoclonal antibodies for scientific in-silico, in-vitro, in-vivo or clinical research and development relating to immuno-oncology, auto-immunity and inflammation. | ACTIVE | — |
| 005 | Pharmaceutical products, including substances and preparations for human use; biopharmaceutical substances and preparations for human use. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 21, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 21, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 20, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 19, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 9, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 9, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 4, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |